{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:40:27Z","timestamp":1792665627954,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","award":["AZ-9B783-M.M.\/S.B.T."],"award-info":[{"award-number":["AZ-9B783-M.M.\/S.B.T."]}],"id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 401821119\\u2013Research Training Group GRK2504.1-2\/A1"],"award-info":[{"award-number":["DFG 401821119\\u2013Research Training Group GRK2504.1-2\/A1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG individual grant (MA 1289\/21-1)"],"award-info":[{"award-number":["DFG individual grant (MA 1289\/21-1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.virusres.2026.199799","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:42:59Z","timestamp":1789195379000},"page":"199799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The murine correlate of the Epstein-Barr and Kaposi\u2019s sarcoma-associated \u03b3-herpesviruses, MHV-68, represents a valuable model to assess antiviral drug sensitivity and combinatorial drug synergies"],"prefix":"10.1016","volume":"373","author":[{"given":"Christina","family":"Wangen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8984-0340","authenticated-orcid":false,"given":"Debora","family":"Obergf\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-3565","authenticated-orcid":false,"given":"Katar\u00edna","family":"Briestensk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jela","family":"Mistr\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.virusres.2026.199799_bib0001","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/molecules24050997","article-title":"Novel therapeutics for Epstein(-)Barr Virus","volume":"24","author":"Andrei","year":"2019","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.virusres.2026.199799_bib0002","first-page":"468","article-title":"Isolation of five strains of herpesviruses from two species of free living small rodents","volume":"24","author":"Bla\u0161kovi\u010d","year":"1980","journal-title":"Acta Virol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199799_bib0003","first-page":"225","article-title":"Experimental pathogenesis of murine herpesvirus in newborn mice","volume":"28","author":"Bla\u0161kovi\u010d","year":"1984","journal-title":"Acta Virol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199799_bib0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4149\/av_2020_206","article-title":"Murid herpesvirus 4 (MuHV-4, prototype strain MHV-68) as an important model in global research of human oncogenic gammaherpesviruses","volume":"64","author":"Briestensk\u00e1","year":"2020","journal-title":"Acta. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2026.199799_bib0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4149\/av_2019_411","article-title":"Recombinant luciferase-expressing murine gammaherpesvirus 68 as a tool for rapid antiviral screening","volume":"63","author":"Briestenska","year":"2019","journal-title":"Acta. Virol."},{"key":"10.1016\/j.virusres.2026.199799_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1059133","article-title":"EBV-associated diseases: current therapeutics and emerging technologies","volume":"13","author":"Chakravorty","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.virusres.2026.199799_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011781","article-title":"A small molecule exerts selective antiviral activity by targeting the human cytomegalovirus nuclear egress complex","volume":"19","author":"Chen","year":"2023","journal-title":"PLoS. Pathog."},{"issue":"17","key":"10.1016\/j.virusres.2026.199799_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713066","article-title":"The impact of Co-infections for Human gammaherpesvirus infection and associated pathologies","volume":"24","author":"Chinna","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.virusres.2026.199799_bib0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2013.07.009","article-title":"Antiviral activity of angelicin against gammaherpesviruses","volume":"100","author":"Cho","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2026.199799_bib0010","unstructured":"Chou, T.M.N., 2005. CompuSyn for Drug Combinations: PC Software and User\u2019s Guide: A Computer Program for Quantitation of Synergism and Antagonism in Drug Combinations, and the Determination of IC50 and ED50 and LD50 Values. Paramus, NJ."},{"issue":"4","key":"10.1016\/j.virusres.2026.199799_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0952-7915(97)80098-2","article-title":"Tuning into immunological dissonance: an experimental model for infectious mononucleosis","volume":"9","author":"Doherty","year":"1997","journal-title":"Curr. Opin. Immunol."},{"issue":"22","key":"10.1016\/j.virusres.2026.199799_bib0012","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1073\/pnas.2002392117","article-title":"Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase","volume":"117","author":"Drosu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt 6","key":"10.1016\/j.virusres.2026.199799_bib0013","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1099\/0022-1317-71-6-1365","article-title":"Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri","volume":"71","author":"Efstathiou","year":"1990","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199799_bib0014","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/IR:25:3:201","article-title":"A mouse model for infectious mononucleosis","volume":"25","author":"Fla\u00f1o","year":"2002","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.virusres.2026.199799_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/viro.2001.0965","article-title":"12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase","volume":"286","author":"Gao","year":"2001","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virusres.2026.199799_bib0016","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/JVI.76.3.998-1003.2002","article-title":"Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the l-riboside benzimidazole 1263W94","volume":"76","author":"Gershburg","year":"2002","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2026.199799_bib0017","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.bbamcr.2015.03.011","article-title":"PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction","volume":"1853","author":"Gonnella","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"24","key":"10.1016\/j.virusres.2026.199799_bib0018","doi-asserted-by":"crossref","first-page":"12498","DOI":"10.1128\/JVI.01152-08","article-title":"Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo","volume":"82","author":"Hwang","year":"2008","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199799_bib0019","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/v13030462","article-title":"Properties of oligomeric interaction of the Cytomegalovirus core nuclear egress complex (NEC) and its sensitivity to an NEC inhibitory small molecule","volume":"13","author":"Kicuntod","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.virusres.2026.199799_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27062627","article-title":"Identification of a new phosphorylated host interactor of the Epstein-Barr Virus (EBV) kinase BGLF4 suggests key points for EBV-specific antiviral drug targeting","volume":"27","author":"K\u00f6gler","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.virusres.2026.199799_bib0021","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","article-title":"Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom","volume":"20","author":"Kuri","year":"2020","journal-title":"BMC. Public Health"},{"key":"10.1016\/j.virusres.2026.199799_bib0022","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","article-title":"Spectrum of Epstein-Barr virus-associated diseases","volume":"1","author":"Kutok","year":"2006","journal-title":"Annu Rev. Pathol."},{"issue":"7900","key":"10.1016\/j.virusres.2026.199799_bib0023","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.virusres.2026.199799_bib0024","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40263-024-01153-5","article-title":"Repurposing licensed drugs with activity against Epstein-Barr virus for treatment of multiple sclerosis: a systematic approach","volume":"39","author":"Li","year":"2025","journal-title":"CNS. Drugs"},{"issue":"1","key":"10.1016\/j.virusres.2026.199799_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2487","article-title":"Targeting EBV-encoded products: implications for drug development in EBV-associated diseases","volume":"34","author":"Lv","year":"2024","journal-title":"Rev. Med. Virol."},{"issue":"Pt 6","key":"10.1016\/j.virusres.2026.199799_bib0026","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1099\/0022-1317-78-6-1425","article-title":"Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68","volume":"78","author":"Mackett","year":"1997","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199799_bib0027","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.05908-11","article-title":"In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses","volume":"56","author":"Marschall","year":"2012","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"19","key":"10.1016\/j.virusres.2026.199799_bib0028","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1128\/JVI.77.19.10488-10503.2003","article-title":"Transcription program of murine gammaherpesvirus 68","volume":"77","author":"Martinez-Guzman","year":"2003","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199799_bib0029","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4149\/av_2020_206","article-title":"Murid herpesvirus 4 (MuHV-4, prototype strain MHV-68) as an important model in global research of human oncogenic gammaherpesviruses","volume":"64","author":"Mistr\u00edkov\u00e1","year":"2020","journal-title":"Acta. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2026.199799_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ph18101560","article-title":"New assay systems to characterize the broad-spectrum antiherpesviral and non-herpesviral activity of cyclin-dependent kinase (CDK) 8 inhibitors","volume":"18","author":"Obergf\u00e4ll","year":"2025","journal-title":"Pharmaceuticals. (Basel)"},{"issue":"9","key":"10.1016\/j.virusres.2026.199799_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16091238","article-title":"Cyclin-dependent kinase 8 represents a positive regulator of Cytomegalovirus replication and a novel host target for antiviral strategies","volume":"16","author":"Obergf\u00e4ll","year":"2024","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.virusres.2026.199799_bib0032","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/cancers10060197","article-title":"Antiviral drugs for EBV","volume":"10","author":"Pagano","year":"2018","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.virusres.2026.199799_bib0033","series-title":"MacSynergy II User\u2019s Manual","author":"Prichard","year":"1992"},{"issue":"1","key":"10.1016\/j.virusres.2026.199799_bib0034","first-page":"51","article-title":"Pathogenesis of acute and persistent murine herpesvirus infection in mice","volume":"29","author":"Raj\u010d\u00e1ni","year":"1985","journal-title":"Acta Virol."},{"issue":"7","key":"10.1016\/j.virusres.2026.199799_bib0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0966-842X(98)01306-7","article-title":"Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis","volume":"6","author":"Simas","year":"1998","journal-title":"Trends. Microbiol."},{"issue":"8","key":"10.1016\/j.virusres.2026.199799_bib0036","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1128\/JVI.73.8.6405-6414.1999","article-title":"Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus","volume":"73","author":"Smith","year":"1999","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2026.199799_bib0037","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.0404521102","article-title":"Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis","volume":"102","author":"Song","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virusres.2026.199799_bib0038","first-page":"31","article-title":"Of mice and men: murine gammaherpesvirus 68 as a model","volume":"6","author":"Stewart","year":"1999","journal-title":"Epstein Barr Virus Report"},{"issue":"4","key":"10.1016\/j.virusres.2026.199799_bib0039","first-page":"818","article-title":"Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68","volume":"145","author":"Sunil-Chandra","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"Pt 9","key":"10.1016\/j.virusres.2026.199799_bib0040","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/0022-1317-73-9-2347","article-title":"Virological and pathological features of mice infected with murine gamma-herpesvirus 68","volume":"73","author":"Sunil-Chandra","year":"1992","journal-title":"J. Gen. Virol."},{"issue":"Pt 12","key":"10.1016\/j.virusres.2026.199799_bib0041","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1099\/0022-1317-73-12-3275","article-title":"Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo","volume":"73","author":"Sunil-Chandra","year":"1992","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2026.199799_bib0042","first-page":"256","article-title":"Growth characteristics of herpesviruses isolated from free living small rodents","volume":"26","author":"Svobodov\u00e1","year":"1982","journal-title":"Acta. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199799_bib0043","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2025.12.032","article-title":"Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis","volume":"189","author":"Thomas","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2026.199799_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106168","article-title":"The conserved core nuclear egress complex (NEC) as an antiherpesviral drug target: pharmacophore-based identification of NEC-specific inhibitors","volume":"239","author":"Tillmanns","year":"2025","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.virusres.2026.199799_bib0045","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/cells12081162","article-title":"Assessment of covalently binding warhead compounds in the validation of the Cytomegalovirus nuclear egress complex as an antiviral target","volume":"12","author":"Tillmanns","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.virusres.2026.199799_bib0046","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.3390\/ijms25052823","article-title":"Getting better'-is it a feasible strategy of broad pan-antiherpesviral drug targeting by using the nuclear egress-directed mechanism?","volume":"25","author":"Tillmanns","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.virusres.2026.199799_bib0047","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.185.9.1641","article-title":"Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?","volume":"185","author":"Tripp","year":"1997","journal-title":"J. Exp. Med."},{"issue":"Pt 4","key":"10.1016\/j.virusres.2026.199799_bib0048","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1099\/0022-1317-77-4-627","article-title":"Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells","volume":"77","author":"Usherwood","year":"1996","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2026.199799_bib0049","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1128\/jvi.71.8.5894-5904.1997","article-title":"Complete sequence and genomic analysis of murine gammaherpesvirus 68","volume":"71","author":"Virgin","year":"1997","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2026.199799_bib0050","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1128\/JVI.73.6.4651-4661.1999","article-title":"B cells regulate murine gammaherpesvirus 68 latency","volume":"73","author":"Weck","year":"1999","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2026.199799_bib0051","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3390\/ijms23052493","article-title":"Cyclin-dependent kinases (CDKs) and the Human Cytomegalovirus-encoded CDK ortholog pUL97 represent highly attractive targets for synergistic drug combinations","volume":"23","author":"Wild","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.virusres.2026.199799_bib0052","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3390\/pharmaceutics15122680","article-title":"Combined treatment with host-directed and anticytomegaloviral kinase inhibitors: mechanisms, synergisms and drug resistance barriers","volume":"15","author":"Wild","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.virusres.2026.199799_bib0053","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/ijms22020575","article-title":"Combinatorial drug treatments reveal promising anticytomegaloviral profiles for clinically relevant pharmaceutical kinase inhibitors (PKIs)","volume":"22","author":"Wild","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virusres.2026.199799_bib0054","article-title":"Construction and characterization of an infectious murine gammaherpesivrus-68 bacterial artificial chromosome","volume":"2011","author":"Wu","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199799_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/pharmaceutics16020158","article-title":"An antiherpesviral host-directed strategy based on CDK7 covalently binding drugs: target-selective, picomolar-dose, cross-virus reactivity","volume":"16","author":"Yu","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.virusres.2026.199799_bib0056","doi-asserted-by":"crossref","first-page":"9829","DOI":"10.1038\/s41598-019-45986-3","article-title":"A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses","volume":"9","author":"Zanella","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:06:33Z","timestamp":1792663593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0168170226001188"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199799","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The murine correlate of the Epstein-Barr and Kaposi\u2019s sarcoma-associated \u03b3-herpesviruses, MHV-68, represents a valuable model to assess antiviral drug sensitivity and combinatorial drug synergies","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199799"}}